Bayesian Capital Management’s Inovalon Holdings, Inc. Class A Common Stock INOV Stock Holding History

Bayesian Capital Management’s Portfolio INOV Stock Details INOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-10,000	Closed	-$193K	–	758
2020 Q2	$193K	Sell	10,000 -9,900	-50%	-$176K	0.04%	441
2020 Q1	$332K	Buy	19,900 +5,400	+37%	+$102K	0.07%	415
2019 Q4	$273K	Buy	+14,500	New	+$243K	0.05%	452
2017 Q4	–	Sell	-10,873	Closed	-$185K	–	777
2017 Q3	$185K	Buy	+10,873	New	+$152K	0.04%	433
2017 Q1	–	Sell	-33,400	Closed	-$344K	–	762
2016 Q4	$344K	Buy	+33,400	New	+$456K	0.09%	393

Other funds holding INOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BCA

Bernzott Capital Advisors Camarillo, California $209M AUM 9.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Bayesian Capital Management's INOV Position: Q3 2020 in Review

Bayesian Capital Management sold out of Inovalon Holdings, Inc. Class A Common Stock (INOV) in Q3 2020, closing a stake of 10,000 shares — an estimated $193K sold.

Bayesian Capital Management first reported a position in INOV in Q4 2016 and held it in 5 quarters. The position peaked at $344K in Q4 2016. 181 funds tracked by Wall St. Rank hold INOV as of Q3 2020.

Bayesian Capital Management reported no remaining Inovalon Holdings, Inc. Class A Common Stock position as of Q3 2020 after selling out during the quarter.
Bayesian Capital Management sold 10,000 Inovalon Holdings, Inc. Class A Common Stock shares in Q3 2020, an estimated $193K.
Bayesian Capital Management first reported a position in Inovalon Holdings, Inc. Class A Common Stock in Q4 2016 and held it in 5 quarters.
Bayesian Capital Management's Inovalon Holdings, Inc. Class A Common Stock position peaked at $344K in Q4 2016.
181 funds tracked by Wall St. Rank held Inovalon Holdings, Inc. Class A Common Stock as of Q3 2020.

Based on Bayesian Capital Management's 13F filing for Q3 2020, filed 12 Nov 2020.